Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Designing early detection programs for ovarian cancer.

Literature DB >> 22180403

Designing early detection programs for ovarian cancer.

Abstract

Human epididymis protein 4 (HE4) shows promise as a serum marker that complements CA125 in the early detection of epithelial ovarian cancer, either as a first-line screen or as a second-line screen in a multimodal strategy. Incorporation of symptoms in a screening strategy that includes CA125 and HE4 may warrant further research.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 22180403 PMCID： PMC3280618 DOI： 10.1093/annonc/mdr472

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

10 in total

1. A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker.

Authors: Martin W McIntosh; Nicole Urban
Journal: Biostatistics Date: 2003-01 Impact factor: 5.899

2. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.

Authors: Richard G Moore; Moune Jabre-Raughley; Amy K Brown; Katina M Robison; M Craig Miller; W Jeffery Allard; Robert J Kurman; Robert C Bast; Steven J Skates
Journal: Am J Obstet Gynecol Date: 2010-05-14 Impact factor: 8.661

3. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.

Authors: Hala A Abdel-Azeez; Hany A Labib; Samar M Sharaf; Ashraf N Refai
Journal: Asian Pac J Cancer Prev Date: 2010

4. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

Authors: Claire S Zhu; Paul F Pinsky; Daniel W Cramer; David F Ransohoff; Patricia Hartge; Ruth M Pfeiffer; Nicole Urban; Gil Mor; Robert C Bast; Lee E Moore; Anna E Lokshin; Martin W McIntosh; Steven J Skates; Allison Vitonis; Zhen Zhang; David C Ward; James T Symanowski; Aleksey Lomakin; Eric T Fung; Patrick M Sluss; Nathalie Scholler; Karen H Lu; Adele M Marrangoni; Christos Patriotis; Sudhir Srivastava; Saundra S Buys; Christine D Berg
Journal: Cancer Prev Res (Phila) Date: 2011-03

5. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Authors: Daniel W Cramer; Robert C Bast; Christine D Berg; Eleftherios P Diamandis; Andrew K Godwin; Patricia Hartge; Anna E Lokshin; Karen H Lu; Martin W McIntosh; Gil Mor; Christos Patriotis; Paul F Pinsky; Mark D Thornquist; Nathalie Scholler; Steven J Skates; Patrick M Sluss; Sudhir Srivastava; David C Ward; Zhen Zhang; Claire S Zhu; Nicole Urban
Journal: Cancer Prev Res (Phila) Date: 2011-03

6. The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass.

Authors: Martina Montagnana; Giuseppe Lippi; Orazio Ruzzenente; Valentina Bresciani; Elisa Danese; Silvia Scevarolli; Gian Luca Salvagno; Silvia Giudici; Massimo Franchi; Gian Cesare Guidi
Journal: J Clin Lab Anal Date: 2009 Impact factor: 2.352

7. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors: Usha Menon; Aleksandra Gentry-Maharaj; Rachel Hallett; Andy Ryan; Matthew Burnell; Aarti Sharma; Sara Lewis; Susan Davies; Susan Philpott; Alberto Lopes; Keith Godfrey; David Oram; Jonathan Herod; Karin Williamson; Mourad W Seif; Ian Scott; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Nazar N Amso; Simon Leeson; Derek Cruickshank; Alistair McGuire; Stuart Campbell; Lesley Fallowfield; Naveena Singh; Anne Dawnay; Steven J Skates; Mahesh Parmar; Ian Jacobs
Journal: Lancet Oncol Date: 2009-03-11 Impact factor: 41.316

8. Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Authors: M Robyn Andersen; Barbara A Goff; Kimberly A Lowe; Nathalie Scholler; Lindsay Bergan; Charles W Drescher; Pamela Paley; Nicole Urban
Journal: Gynecol Oncol Date: 2009-11-28 Impact factor: 5.482

9. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

Authors: Garnet L Anderson; Martin McIntosh; Lieling Wu; Matt Barnett; Gary Goodman; Jason D Thorpe; Lindsay Bergan; Mark D Thornquist; Nathalie Scholler; Nam Kim; Kathy O'Briant; Charles Drescher; Nicole Urban
Journal: J Natl Cancer Inst Date: 2009-12-30 Impact factor: 13.506

10. Results from four rounds of ovarian cancer screening in a randomized trial.

Authors: Edward Partridge; Aimee R Kreimer; Robert T Greenlee; Craig Williams; Jian-Lun Xu; Timothy R Church; Bruce Kessel; Christine C Johnson; Joel L Weissfeld; Claudine Isaacs; Gerald L Andriole; Sheryl Ogden; Lawrence R Ragard; Saundra S Buys
Journal: Obstet Gynecol Date: 2009-04 Impact factor: 7.623

10 in total

6 in total

6. Retrospective Study of the Epidemiology, Pathology, and Therapeutic Management in Patients With Mucinous Ovarian Tumors.

Authors: Yuanyuan Zhang; Chunmei Li; Suiyu Luo; Ying Su; Xiaoqing Gang; Peiyuan Chu; JuXin Zhang; Henghui Wu; Guangzhi Liu
Journal: Technol Cancer Res Treat Date: 2020 Jan-Dec